Antolina Moreno

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?

A. Sánchez-Fructuoso, M. Hurtado, M. Velo, 2020, American Journal of Transplantation.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.